PHVS Competitors & Alternatives
Compare Pharvaris BV with similar stocks in the same industry
Biotechnology
PHVS
Main Stock$32.62
Tradestie Score
59
Market Cap
$1.55B
Analyst Upside
+46.7%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
TARS
Tarsus Pharmaceuticals, Inc. Common Stock
|
$59.04
|
$2.42B | - | 46 | Compare |
|
BLTE
Belite Bio, Inc American Depositary Shares
|
$158.61
|
$2.41B | - | 51 | Compare |
|
IDYA
IDEAYA Biosciences, Inc. Common Stock
|
$35.50
|
$2.40B | - | 56 | Compare |
|
FOLD
Amicus Therapeutics, Inc
|
$14.49
|
$2.38B | - | 60 | Compare |
|
ARQT
Arcutis Biotherapeutics, Inc. Common Stock
|
$26.86
|
$2.37B | - | 57 | Compare |
|
APGE
Apogee Therapeutics, Inc. Common Stock
|
$134.09
|
$2.35B | - | 47 | Compare |
|
IBRX
ImmunityBio, Inc. Common Stock
|
$7.17
|
$2.34B | - | 47 | Compare |
|
IRON
Disc Medicine, Inc. Common Stock
|
$77.00
|
$2.33B | - | 60 | Compare |
|
AGIO
Agios Pharmaceuticals, Inc.
|
$30.02
|
$2.33B | - | 50 | Compare |
|
GLPG
Galapagos NV
|
$27.73
|
$2.31B | 5.1 | 59 | Compare |
More PHVS Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2834)
229 stocks in this industry